The correct answer is (a) True
Easiest explanation: There are a range of applications in which Fc mediated effects are not required and are even undesirable. A common solution for applications where the antibody is only being used to block a signalling molecule or receptor is the use of antibody fragments that lack the Fc domain. This also helps to reduce the other main failure of therapeutic antibodies, namely the lack of delivery, which is especially true for anti-cancer antibodies.